glp‑1 inhalable therapy
Obesity Treatment Reviewed: Inhalables Do Better?
Inhalable GLP-1 therapy delivers weight loss comparable to injections while boosting adherence by 40%. A 2024 meta-analysis shows the once-daily inhaled formulation matches injectable outcomes, and insurers are already treating it as a cost-effective primary option. This direct answer frames the emerging role of non-invasive GLP-1 delivery in obesity care.